Emerging spread of new fungal species poses risk for healthcare settings in the EU/EEA
The rise in Europe of Candida auris infections, a difficult-to-control fungus, is of concern. The fungus spreads easily in healthcare settings, can cause invasive infections, and is also associated with resistance to multiple classes of anti-fungal medication.
Europol and ECDC organised second Cross-sectoral Biorisk Awareness and Mitigation Training
The European Union Agency for Law Enforcement Cooperation (EUROPOL) and the European Centre for Disease Prevention and Control (ECDC), organised the second edition of the Cross-sectoral Biorisk Awareness and Mitigation Training, hosted in Olhão, Portugal, on 17 - 19 April 2018.
Measles cases increase significantly in the last month in a number of EU/EEA countries
Measles cases continue to increase in a number of EU/EEA countries. The highest number of cases to date in 2018 were in Romania (1 709), Greece (1 463) France (1 346) and Italy (411) respectively.
Epidemiological update: multi-country outbreak of Listeria monocytogenes serogroup IVb, multi-locus sequence type 6 infections
Since the publication of the joint ECDC-EFSA rapid outbreak assessment on a multi-country outbreak of Listeria monocytogenes serogroup IVb, multi-locus sequence type 6 (ST 6) on 22 March 2018, three EU Member States have reported nine new confirmed outbreak cases.
First cases of Borna disease virus 1 (BoDV-1) transmission through organ transplantation – ECDC risk assessment
On 7 March 2018, Germany reported four human cases of acute encephalitis or encephalopathy caused by infection with Borna disease virus 1 (BoDV-1). This is the first time that a possible BoDV-1 transmission through organ transplantation has been reported.
Epidemiological update: hepatitis A outbreak in the EU/EEA mostly affecting men who have sex with men
Since the last epidemiological update on this multi-country hepatitis A outbreak published on 22 December 2017, 22 EU/EEA countries (Austria, Belgium, Croatia, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Latvia, Luxembourg, Malta, the Netherlands, Norway, Portugal, Slovenia, Spain, Sweden and the United Kingdom-England) have reported 320 new outbreak-confirmed cases. The outbreak-confirmed cases are EU/EEA residents with laboratory-confirmed hepatitis A virus (HAV) genotype IA and a sequence with ≥99.3% homology to one of the three HAV genotype IA outbreak strains (VRD_521_2016; RIVM-HAV16-090; and V16-25801) based on overlapping fragments at the VP1-2a region.